Illustrative data. Not from a real patient. Not actual sizes and not to scale.

How the


Digital technology meets medicine in a smart pill.

Meet the ABILIFY MYCITE® System

Watch this video to learn how the system works.

It’s all connected

After it is swallowed, ABILIFY MYCITE® (aripiprazole tablets with sensor) sends a tiny signal to a wearable Bluetooth®* patch that connects with your smartphone, allowing you to see your daily data all in one place.

Bluetooth is a registered trademark of Bluetooth SIG, Inc.
ABILIFY MYCITE® (aripiprazole tablets with sensor) tablet

Not actual size.


ABILIFY MYCITE is a prescription smart pill with built-in technology the size of a grain of sand. The sensor is made entirely of ingredients found in most diets. It passes through your body naturally.

More questions about the pill?

Check FAQs


Not actual size.


The nonmedicated MYCITE® Patch gets a signal from the smart pill after you swallow it.

The patch is made up of 2 parts:

  • a reusable Bluetooth® data pod
  • a disposable adhesive strip that holds the pod in place

The pod logs when you take your pill. Like an activity tracker, the pod also automatically logs your steps and time spent resting. The pod then sends the information to an app on your smartphone.

The patch can stay on even through water and sweat, and does not need to be taken off in the shower or during exercise.

More questions about the patch?

Check FAQs


Illustrative data. Not from a real patient.


The MYCITE® App receives and displays the information from the Bluetooth patch, such as when you take your ABILIFY MYCITE pill. On the app, you can complete a daily check-in to record your mood, mood contributors, and how well you rested. You can also look at charts of your daily data and access a library of coping activities.

More questions about the app? 

Learn more

welcome screen image

Illustrative data. Not from real patients.


The MYCITE® Dashboard is an online portal that lets your healthcare team and your support network see the data you share with them, like when you took your ABILIFY MYCITE pill, what's contributing to your mood, and how well you rested.

Conversation bubbles, icon


The ABILIFY MYCITE System can help guide the conversation with your healthcare team and support network about your mental health and treatment plan.

It is not known if ABILIFY MYCITE can improve how well you take your aripiprazole (patient compliance) or for changing your dose of aripiprazole. Some factors, such as a bad connection or reception, or not having your smartphone, may impact the consistency and reliability of data being detected, collected, and transmitted.

Only functions related to tracking drug ingestion have been evaluated or approved by FDA.

Sharing data on the MYCITE App

This is your system, your data. How you choose to share your data is up to you. Your healthcare provider will be able to see your data automatically when you finish setup. And if you want, you can also share the daily data you see on the MYCITE App with other members of your healthcare team, like your nurse or therapist. You can also share with those in your support network, like your family or friends.

The people you choose to share your information with will be able to see your data on the MYCITE Dashboard, allowing them to quickly check in and see how you’re doing.

You can change what information you are sharing at any time.

Your data are encrypted and stored securely in the cloud to protect your privacy

Data Encryption Cloud, Icon

The ABILIFY MYCITE System was designed with the privacy of patients’ personal information in mind. Only people chosen by you may view your information, and you may change what information you want to share at any time.

For more information about the system's privacy requirements for you, your healthcare provider team, and family & friends, please review the ABILIFY MYCITE System Terms of Use, Privacy Notice, and Authorization & Consent.

Is the ABILIFY MYCITE System the right fit for you?

Find out
Not a real patient.





  • Increased risk of death in elderly patients with dementia-related psychosis: Medicines like ABILIFY MYCITE can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). ABILIFY MYCITE is not approved to treat patients with dementia-related psychosis.
  • Increased risk of suicidal thoughts or actions in children and young adults: Antidepressant medicines may increase suicidal thoughts or actions in some children and young adults within the first few months of treatment and when the dose is changed. Pay close attention to any changes, especially new and sudden changes, in mood, behaviors, thoughts, or feelings and report them to the healthcare provider. It is not known if ABILIFY MYCITE is safe and effective for use in children.

Do not take ABILIFY MYCITE if you are allergic to aripiprazole or any of the ingredients in ABILIFY MYCITE. Allergic reactions may include: rash, hives, itching, difficulty breathing, tightness in the chest, swelling of the mouth, face, lips, or tongue.

ABILIFY MYCITE may cause serious side effects, including:

  • Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
  • Neuroleptic malignant syndrome (NMS), a rare and serious condition that can lead to death. Call your healthcare provider or go to the nearest hospital emergency room right away if you have some or all of the following signs and symptoms of NMS: high fever, stiff muscles, confusion, sweating, changes in pulse, heart rate, and blood pressure.
  • Uncontrolled body movements (tardive dyskinesia or TD). ABILIFY MYCITE may cause movements that you cannot control in your face, tongue, or other body parts. TD may not go away, even if you stop taking ABILIFY MYCITE. TD may also start after you stop taking ABILIFY MYCITE.
  • Problems with your metabolism such as:
    • high blood sugar (hyperglycemia) and diabetes. Increases in blood sugar can happen in some people who take ABILIFY MYCITE. Extremely high blood sugar can lead to coma or death. If you have diabetes or risk factors for diabetes (such as being overweight or a family history of diabetes), your healthcare provider should check your blood sugar before starting ABILIFY MYCITE and during your treatment.

      Call your healthcare provider if you have any of these symptoms of high blood sugar while receiving ABILIFY MYCITE:

      • feel very thirsty
      • need to urinate more than usual
      • feel very hungry
      • feel weak or tired
      • feel sick to your stomach
      • feel confused, or your breath smells fruity
    • increased fat levels (cholesterol and triglycerides) in your blood.
    • weight gain. You and your healthcare provider should check your weight regularly.
  • Unusual urges. Some people taking aripiprazole have had unusual urges, such as gambling, binge eating or eating that you cannot control (compulsive), compulsive shopping and sexual urges. If you or your family members notice that you are having unusual urges or behaviors, talk to your healthcare provider.
  • Decreased blood pressure (orthostatic hypotension). You may feel lightheaded or faint when you rise too quickly from a sitting or lying position.

  • Falls

  • Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment with ABILIFY MYCITE.

  • Seizures (convulsions)

  • Problems with control of your body temperature so that you feel too warm. Do not become too hot or dehydrated during treatment with ABILIFY MYCITE. Avoid getting over-heated or dehydrated. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Stay out of the sun, and do not wear too much or heavy clothing. Drink plenty of water.

  • Difficulty swallowing

ABILIFY MYCITE may make you drowsy. Do not drive, operate heavy machinery, or do other dangerous activities until you know how ABILIFY MYCITE affects you.

Before taking ABILIFY MYCITE, tell your healthcare provider if you:

  • have or had diabetes or high blood sugar in you or your family; your healthcare provider should check your blood sugar before starting and during therapy with ABILIFY MYCITE
  • have or had seizures (convulsions)
  • have or had low or high blood pressure
  • have or had heart problems or stroke
  • have or had low white blood cell count
  • are pregnant or have plans to become pregnant. It is not known if ABILIFY MYCITE will harm your unborn baby.
  • are breast-feeding or have plans to breast-feed. ABILIFY MYCITE can pass into your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive ABILIFY MYCITE
  • have or had any other medical conditions

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ABILIFY MYCITE and other medicines may affect each other causing possible serious side effects. ABILIFY MYCITE may affect the way other medicines work, and other medicines may affect how ABILIFY MYCITE works. Do not start or stop any medicines while taking ABILIFY MYCITE without talking to your healthcare provider first.

The most common side effects of ABILIFY MYCITE in adults include: restlessness or need to move (akathisia); dizziness; nausea; insomnia; shaking (tremor); anxiety; constipation; sedation

These are not all the possible side effects of ABILIFY MYCITE. Call your doctor for medical advice about side effects. You are encouraged to report side effects to Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 or




See INDICATIONS or ABILIFY MYCITE® (aripiprazole tablets with sensor):

ABILIFY MYCITE is a prescription medicine of an aripiprazole tablet with an Ingestible Event Marker (IEM) sensor inside it used in adults for the:

  • Treatment of schizophrenia
  • Treatment of bipolar I disorder alone or when used with the medicine lithium or valproate for:
    • acute (short-term) treatment of manic or mixed episodes
    • maintenance treatment
  • Treatment of major depressive disorder (MDD) along with other antidepressant medicines

The ABILIFY MYCITE System is intended to track if you have taken your ABILIFY MYCITE. There may be a delay in the detection of the ABILIFY MYCITE tablet and sometimes the detection of the tablet might not happen at all. If the MYCITE APP does not indicate that you have taken your medicine, do not repeat the dose. It is not known if ABILIFY MYCITE can improve how well you take your aripiprazole (patient compliance) or for changing your dose of aripiprazole. ABILIFY MYCITE is not for use as real-time or emergency monitoring.